A citation-based method for searching scientific literature

Low-dose colchicine for secondary prevention of cardiovascular disease.
Stefan M Nidorf, John W Eikelboom, Charley A Budgeon, Peter L Thompson. J Am Coll Cardiol 2013
Times Cited: 479



Mechanism of action of colchicine in the treatment of gout.
Nicola Dalbeth, Thomas J Lauterio, Henry R Wolfe. Clin Ther 2014
Times Cited: 151




List of shared articles



Times cited

Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials.
Ibadete Bytyçi, Gani Bajraktari, Peter E Penson, Michael Y Henein, Maciej Banach. Br J Clin Pharmacol 2022
0

COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): A Descriptive Cytokine Pilot Sub-Study.
Justin Cole, Nay Htun, Robert Lew, Mark Freilich, Stephen Quinn, Jamie Layland. Cardiovasc Revasc Med 2022
2

Colchicine for Patients With Coronary Artery Disease: A Systematic Review and Meta-analysis.
Dhan B Shrestha, Pravash Budhathoki, YubRaj Sedhai, Manoj Khadka, Subashchandra Pokharel, Stuti Yadav, Toralben Patel, Islam Elgendy, Wasey Ali Yadullahi Mir, Nimesh K Patel. J Cardiovasc Pharmacol 2022
1

Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials.
Haiyan Xu, Ling Mao, Hailang Liu, Zhenyu Lin, Yuanyuan Zhang, Jing Yang. Heart Lung Circ 2022
1

Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials.
Yi Chen, Hongzhou Zhang, Yuxin Chen, Meng Li, Wei Luo, Yue Liu, Yang Fu, Huasong Xia, Cong Xu, Yu Jiang,[...]. Clin Rheumatol 2022
0

Resolution-promoting autacoids demonstrate promising cardioprotective effects against heart diseases.
Roddy Hiram. Mol Biol Rep 2022
1

Effect of colchicine on inflammatory markers in patients with coronary artery disease: A meta-analysis of clinical trials.
Zimo Pan, Jiayu Cheng, Wenjia Yang, Lingxia Chen, Jingtong Wang. Eur J Pharmacol 2022
0

Inflammation May be the Future of Cardiovascular Risk Reduction: Does Colchicine have a Current Indication?
Thomas F Whayne. Am J Cardiovasc Drugs 2021
0

Colchicine for the treatment of cardiovascular diseases: old drug, new targets.
Alessandro Andreis, Massimo Imazio, Gaetano Maria De Ferrari. J Cardiovasc Med (Hagerstown) 2021
10

Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Michelle Samuel, Jean-Claude Tardif, Nadia Bouabdallaoui, Paul Khairy, Marie-Pierre Dubé, Lucie Blondeau, Marie-Claude Guertin. Can J Cardiol 2021
32

Drug repurposing? Cardiovascular effect of colchicine on patients with coronary artery disease: A systematic review and meta-analysis.
Yu-Yu Tien, Huei-Kai Huang, Ming-Chieh Shih, Yu-Kang Tu. J Cardiol 2021
6

Medications for gout and its comorbidities: mutual benefits?
Kazuki Yoshida, Hyon K Choi, Daniel H Solomon. Curr Opin Rheumatol 2021
1

Efficacy and safety of colchicine for secondary prevention of coronary heart disease: a systematic review and meta-analysis.
Zujin Xiang, Jian Yang, Jun Yang, Jing Zhang, Zhixing Fan, Chaojun Yang, Liu Di, Cong Ma, Jingyi Wu, Yifan Huang. Intern Emerg Med 2021
3

Update on the Inflammatory Hypothesis of Coronary Artery Disease.
Julia Boland, Carlin Long. Curr Cardiol Rep 2021
3

The Role of Colchicine in Atherosclerotic Cardiovascular Disease.
Rahul Kurup, Keyvan Karimi Galougahi, Gemma Figtree, Ashish Misra, Sanjay Patel. Heart Lung Circ 2021
4


Longstocking, LLC. © 2021
Home | About Us | FAQs | Terms & Privacy